You are here

Article info

Article menu
Hepatology
Original research
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma

Authors

  • Li-Gong Lu Interventional Radiology Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhi-Ling Zhou Interventional Radiology Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong, China PubMed articlesGoogle scholar articles
  • Xu-Yan Wang Interventional Radiology Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong, China PubMed articlesGoogle scholar articles
  • Bo-Yuan Liu Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, Jiangsu, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Jin-Ying Lu Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, Jiangsu, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Shuai Liu Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, Jiangsu, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Guang-Bo Zhang Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Mei-Xiao Zhan Interventional Radiology Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, Guangdong, China PubMed articlesGoogle scholar articles
  • Yun Chen Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, Jiangsu, China Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yun Chen, Nanjing Medical University, Nanjing, China; chenyun{at}njmu.edu.cn; Dr Mei-Xiao Zhan, Zhuhai People's Hospital, Zhuhai, China; zhanmeixiao1987{at}126.com; Dr Guang-Bo Zhang, The First Affiliated Hospital of Soochow University, Suzhou, China; zhanggbsuzhou{at}hotmail.com; Dr Li-Gong Lu, Zhuhai People's Hospital, Zhuhai, China; luligong1969{at}jnu.edu.cn
View Full Text

Citation

Lu L, Zhou Z, Wang X, et al
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
Gut 2022;71:2551-2560.

Publication history

  • Received October 18, 2021
  • Accepted February 6, 2022
  • First published February 16, 2022.
Online issue publication 
May 11, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.